ICU Medical ROA 2006-2019 | ICUI

Current and historical return on assets (ROA) values for ICU Medical (ICUI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. ICU Medical ROA for the three months ending September 30, 2019 was 9.77%.
ICU Medical ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $0.07B $1.64B 4.58%
2019-06-30 $0.05B $1.62B 2.95%
2019-03-31 $0.06B $1.61B 3.51%
2018-12-31 $0.03B $1.59B 1.89%
2018-09-30 $0.09B $1.55B 5.68%
2018-06-30 $0.09B $1.53B 5.70%
2018-03-31 $0.02B $1.49B 1.20%
2017-12-31 $0.07B $1.50B 4.62%
2017-09-30 $0.03B $1.52B 2.24%
2017-06-30 $0.05B $1.49B 4.41%
2017-03-31 $0.10B $1.47B 11.56%
2016-12-31 $0.06B $0.71B 9.51%
2016-09-30 $0.06B $0.69B 9.02%
2016-06-30 $0.06B $0.66B 8.83%
2016-03-31 $0.05B $0.64B 8.68%
2015-12-31 $0.05B $0.63B 7.62%
2015-09-30 $0.05B $0.61B 8.26%
2015-06-30 $0.04B $0.57B 6.75%
2015-03-31 $0.03B $0.55B 5.41%
2014-12-31 $0.03B $0.54B 4.96%
2014-09-30 $0.03B $0.53B 6.23%
2014-06-30 $0.04B $0.52B 7.42%
2014-03-31 $0.04B $0.51B 7.89%
2013-12-31 $0.04B $0.50B 8.61%
2013-09-30 $0.04B $0.47B 8.72%
2013-06-30 $0.04B $0.45B 9.24%
2013-03-31 $0.04B $0.44B 10.04%
2012-12-31 $0.04B $0.43B 10.18%
2012-09-30 $0.05B $0.41B 12.18%
2012-06-30 $0.04B $0.39B 11.94%
2012-03-31 $0.04B $0.38B 12.33%
2011-12-31 $0.04B $0.36B 12.75%
2011-09-30 $0.04B $0.34B 10.53%
2011-06-30 $0.04B $0.35B 10.89%
2011-03-31 $0.03B $0.33B 11.09%
2010-12-31 $0.03B $0.31B 10.14%
2010-09-30 $0.03B $0.30B 9.13%
2010-06-30 $0.02B $0.29B 8.05%
2010-03-31 $0.02B $0.29B 7.30%
2009-12-31 $0.03B $0.31B 8.25%
2009-09-30 $0.03B $0.31B 9.44%
2009-06-30 $0.03B $0.30B 10.47%
2009-03-31 $0.03B $0.29B 10.48%
2008-12-31 $0.03B $0.28B 9.43%
2008-09-30 $0.02B $0.27B 8.63%
2008-06-30 $0.02B $0.26B 7.62%
2008-03-31 $0.02B $0.25B 6.84%
2007-12-31 $0.02B $0.24B 9.64%
2007-09-30 $0.03B $0.25B 10.03%
2007-06-30 $0.03B $0.26B 10.55%
2007-03-31 $0.03B $0.25B 12.12%
2006-12-31 $0.03B $0.24B 10.83%
2006-09-30 $0.02B $0.24B 10.41%
2006-06-30 $0.02B $0.23B 10.95%
2006-03-31 $0.02B $0.22B 11.03%
2005-12-31 $0.02B $0.21B 10.58%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.830B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $151.583B 20.94
Abbott Laboratories (ABT) United States $151.168B 27.57
Stryker (SYK) United States $76.313B 25.66
Boston Scientific (BSX) United States $61.440B 29.00
Baxter (BAX) United States $42.463B 25.75
Essilor Luxottica (ESLOY) France $33.468B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.550B 19.17
Terumo (TRUMY) Japan $27.062B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.531B 0.00
Coloplast (CLPBY) Denmark $25.294B 39.03
ResMed (RMD) United States $21.653B 39.94
Smith & Nephew SNATS (SNN) United Kingdom $19.279B 0.00
Sunny Optical Technology (SNPTF) China $19.151B 0.00
Insulet (PODD) United States $11.373B 541.06
Bio-Rad Laboratories (BIO) United States $11.201B 53.76
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.203B 21.24
Perrigo (PRGO) Ireland $7.117B 13.27
Canopy Growth (CGC) Canada $6.501B 0.00
Haemonetics (HAE) United States $6.146B 41.53
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.890B 30.64
Neogen (NEOG) United States $3.545B 59.33
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.165B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.121B 0.00
Quidel (QDEL) United States $2.954B 28.04
Aurora Cannabis (ACB) Canada $2.648B 0.00
National Vision Holdings (EYE) United States $2.432B 54.89
Agios Pharmaceuticals (AGIO) United States $2.411B 0.00
Cardiovascular Systems (CSII) United States $1.577B 0.00
InMode (INMD) Israel $1.516B 0.00
AtriCure (ATRC) United States $1.226B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.162B 23.28
Phibro Animal Health (PAHC) United States $0.994B 18.61
NanoString Technologies (NSTG) United States $0.944B 0.00
Lantheus Holdings (LNTH) United States $0.802B 20.04
Eagle Pharmaceuticals (EGRX) United States $0.771B 29.55
TG Therapeutics (TGTX) United States $0.709B 0.00
Quanterix (QTRX) United States $0.705B 0.00
LeMaitre Vascular (LMAT) United States $0.698B 39.25
PetIQ (PETQ) United States $0.675B 16.46
Omeros (OMER) United States $0.655B 0.00
Cerus (CERS) United States $0.574B 0.00
Surmodics (SRDX) United States $0.570B 59.24
HEXO (HEXO) $0.537B 0.00
OraSure Technologies (OSUR) United States $0.492B 29.52
Owens & Minor (OMI) United States $0.474B 17.53
MacroGenics (MGNX) United States $0.474B 0.00
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.71
Meridian Bioscience (VIVO) United States $0.396B 13.62
BioLife Solutions (BLFS) United States $0.331B 134.92
Zynex (ZYXI) United States $0.329B 37.22
Bovie Medical (APYX) United States $0.275B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
United Health Products (UEEC) United States $0.249B 0.00
Viemed Healthcare (VMD) United States $0.242B 25.52
Vapotherm (VAPO) United States $0.227B 0.00
Repro-Med Systems (KRMD) United States $0.195B 0.00
Liberty Health Sciences (LHSIF) Canada $0.192B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
InfuSystems Holdings (INFU) United States $0.153B 773.00
Chimerix (CMRX) United States $0.151B 0.00
Female Health (VERU) United States $0.148B 0.00
Rockwell Medical (RMTI) United States $0.141B 0.00
Cytosorbents (CTSO) United States $0.128B 0.00
Fonar (FONR) United States $0.128B 9.03
MTech Acquisition (KERN) United States $0.114B 0.00
United-Guardian (UG) United States $0.091B 23.15
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
MRI Interventions (MRIC) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00